March 9, 2013

Table Saw Injury - Product Liability Lawsuits

Lawyers representing victims who have been injured using table saws must be aware of the flesh-detection technology available that could prevent most of these injuries. The Consumer Product Safety Commission estimates at least 60,000 injuries and 3,000 amputations per year stem from use of table saws in the U.S. Dr. Stephen Gass, the inventor of the flesh-detection technology, called Saw Stop, has testified as an expert that this technology should have been incorporated in any table saw manufactured after 2004. The Saw Stop technology detects contact between human flesh and a saw blade so that accidents that might otherwise have resulted in a severe laceration or amputation will cause only a minor cut or scratch.

Lawsuits claiming that the table saws are unreasonably dangerous generally revolve around the theory that "a feasible alternative design" existed in the form of a saw incorporating Saw Stop technology. Dr. Gass and others have testified that it is technically, practically and economically feasible to have the Saw Stop technology incorporated into all table saws.

Illinois law requires plaintiff in a product liability lawsuit alleging defective design under the risk-utility method to present "evidence of an alternative design that is economical, practical and effective" Mikolajczk v. Ford Motor Co., 231 Ill. 2d 516, 526 (2008). The Illinois Supreme Court has held that "a plaintiff may demonstrate that a product is unreasonably dangerous because of a design defect by presenting evidence of an alternative design that would have prevented injury and was feasible in terms of cost, practicality and technological possibility" Hanson v. Baxter Healthcare, 198 Ill. 2d 420, 436 (2002). According to testimony from Saw Stop's inventor, adding the Saw Stop technology onto existing models of table saws would cost $150 per table saw.

Bringing a lawsuit for injuries received on a table saw without Saw Stop technology will generate the inevitable Daubert challenges to the experts opinions, particularly as to the technical, practical and economic feasibility, but they can be and have been successfully prosecuted. Should you or someone you know suffer a serious injury using a table saw you may wish to call an experienced product liability attorney, Edmund Scanlan, toll free at 877-494-1309 for a free consultation.

December 30, 2012

Illinois De Puy Hip Replacement Statute of Limitations

No Illinois court decisions currently interpret when the statute of limitations expires on De Puy Hip Replacements lawsuits, but there are decisions by both the Illinois Supreme and Appellate courts that provide guidance. Illinois products liability statute of limitations is found at 735 ILCS 5/13-213(d) which provides that: " ...the plaintiff may bring an action within 2 years after the date on which the claimant knew, or through the use of reasonable diligence should have known, of the existence of the personal injury, death...but in no event shall such action be brought more than 8 years after the date on which such personal injury, death...occurred."

The Illinois Supreme Court has held: "...the statute starts to run when a person knows or reasonably should know of his injury and also knows or reasonably should know that it was wrongfully caused." Knox v. Celotex, 88 Ill. 2d 407, 414-415, 430 N.E. 2d 976, 980 (1982). The Illinois high court has also stated that: "...an injured is not held to a standard of knowing the inherently unknowable...yet once it appear that an injury was wrongfully caused, the party may not slumber on his rights." Nolan v. Johns-Mansville, 85 Ill. 2d 161, 171, 421 N.E. 2d 864,, 868 (1981).

On August 24, 2010, De Puy Orthopedics, Inc. instituted a recall of its ASR XL and ASR Hip Replacement Systems. These systems feature chromium and cobalt in its ball-and-socket design. In light of the Illinois decisions interpretting the "discovery rule" it appears that patients with De Puy hip replacements that have failed have 2 years from the date they noticed the failure to file suit (See Aug. 5, 2011 blog re: failures). A fair interpretation of Illinois law will lead to the conclusion that the recall of August 24, 2011, puts any person on notice at the time the failure is noticed that it was wrongfully caused by a design defect in the hip replacement system.

A recent analysis of the "discovery rule" is contained in Matias v. I-Flow, 959 N.E. 2d 94 (Ill. App. 2011).The Matias court focused on "wrongful cause" in determining when the two years begins running by stating: "it is a prerequisite for triggering of the statute of limitations that the injured plaintiff have actual or constructive notice of the possibility that someone is at fault for the injury's existence." In De Puy cases the the recall of August 24, 2010, may be held to be the triggering event.

Patients and attorneys who have clients with failed De Puy hip replacement systems should not delay in bringing suit on the belief that they weren't sure what caused the failure-the recall will most likely be determined to be the "triggering event" in imputing knowledge. Should you so choose feel free to call Edmund Scanlan, an experienced product liability trial lawyer, toll free at 877-494-1309 for a free consultation. I am currently representing several clients who have failed De Puy hip replacement systems. Do not delay.

May 1, 2012

Second Opinions-Personal Injury Cases

People injured in accidents in Illinois frequently hire an attorney recommended by a friend or who advertises on TV. The lawyer retained will sometimes have little or no jury trial experience-this question should always be asked before retaining the attorney. Oftentimes the client becomes unhappy with the lawyer-lack of communication, attorney lacks the required experience, lawyer referring case out to another lawyer, and many more. Whatever the reason you are entitled to consult with another attorney for a second opinion. I have successfully represented injured victims and their families in personal injury and wrongful death lawsuits in Illinois state courts and federal courts throughout the United States for over 30 years.

On the occasions that I have been contacted for a second opinion the most common questions posed are: Is it possible to change lawyers?-the answer is YES, What will it cost to change lawyers?-the answer is often NOTHING, and Will it hurt my ability to collect full compensation?-the answer normally is NO. Remember that if you suffered injuries as a result of the fault of another you will only get one opportunity to obtain full and fair compensation and unless you have a mutual relationship of trust and respect with your lawyer it is unlikely that your goals will be achieved. It is a fundamental right of every client to discharge his/her attorney and hire another attorney and this decision must be respected by the discharged attorney.

All cases present unique factual and legal issues and we offer free consultation to discuss your case. I take pride in guaranteeing that I will be present with you at all times during the lawsuit from initial consultation, depositions, pretrial conferences, the jury trial, and any appeals that may follow. You will not be referred to another lawyer or firm nor will a young associate handle your case. I remain with my clients all the way through the litigation process. This is important because I have numerous significant verdicts for my clients in personal injury and wrongful death actions including many multi million dollar verdicts. The insurance companies and their lawyers know this-and this significantly increases your opportunity to receive full compensation. Should you so choose feel free to contact Edmund Scanlan toll free at 877-494-1309 for a free telephone or office consultation.

I

March 4, 2012

Online Prescriptions Are Becoming A Public Health Threat

Purchasing prescription drugs over the internet without a valid prescription is shockingly simple. An internet connection, a credit card and basic Google skills are all you need to have prescription drugs delivered to your front door.

The National Association of Boards of Pharmacy (NABP) issued a rare "public health alert" on July 28, 2011. Based on a recent study the NABP found that 96 percent of 8,000 rogue websites analyzed continue to operate out of compliance with U.S. pharmacy laws. In their alert the NABP warned: "The fake online pharmacy crisis has reached an epidemic level, they prey on prescription drug abusers, and the most vulnerable members of society..." Most of these sites will sell prescription drugs without a valid prescription. The National Center on Addiction and Substance Abuse (CAPA) at Colombia University in 2006 found that 9 out of 10 websites selling prescription drugs do not require a prescription.

According to research conducted by the Partnership for a Drugfree.org found that 1 in 6 Americans purchase prescription drugs via the internet without a valid prescription. They also found that from 2000 to 2007 states with the fastest growth of Internet access also had the largest jump in hospital admissions for treatment of prescription drug abuse. The Journal of Health Affairs in May 2011 suggested that the growth of high speed internet access has fueled prescription drug abuse.

The sale of prescription drugs over the internet is extremely lucrative (see my blog of Jan. 18, 2007) and is fueled by the unholy trio of website operators (frequently overseas), the pharmacists, and online prescribing physicians. The physicians who issue prescriptions based on online questionnaires without ever seeing the patient are the most reprehensible. The Ryan Haight Online Pharmacy Consumer Protection Act makes it a felony to prescribe controlled substances over the internet without a valid prescription. However, even the sale of non controlled prescriptions drugs without a valid prescription -patient having a physical examination by a physician- is also a felony (see my blog of December 15, 2011). Late last year Senators Feinstein and Sessions introduced the Online Pharmacy Safety Act of 2011 which makes it a felony to prescribe non controlled prescription drugs without a valid prescription.


If you or a family member have been injured or died as a result of a prescription drug obtained over the internet, you can and should fight back. Medical malpractice and product liability lawsuits against internet pharmacies, pharmacists, and physicians who prescribe without a valid physician-patient relationship are an effective way to secure not only compensation for your losses but also to put a halt to this growing public health threat. Should you wish to discuss your situation further, feel free to contact Edmund Scanlan toll free at 877-494-1309.

February 12, 2012

Keeping Illinois DePuy Hip Implant Lawsuits in State Court

Illinois attorneys representing clients who have had recalled DePuy hip prosthesis implanted, should be aware that these lawsuits can be kept in the state courts. Care must be taken in drafting the complaint and attention should be paid to federal civil procedural deadlines regarding remanding a case back to the state court system.

First, the DePuy ASR XL Hip Acetabular System and the ASR Hip Replacement System that were recalled by DePuy Orthopedics in August 2010, were distributed by Premier Orthopedic Sales, Inc., an Illinois corporation (See blog of April 5, 2011). Premier needs to be joined as a defendant along with DePuy Orthopedics, Inc., an Indiana corporation, pursuant to 735 ILCS 5/2-621.
Second, in drafting the complaint against Premier, it is essential that you allege facts that preclude removal pursuant to 735 ILCS5/2-621(c)(1), (2), or (3), specifically:
(1) Premier exercised control over design or manufacture; or
(2) Premiere had knowledge of the defect; or
(3) Premier created the defect.

On February 10, 2012, I filed suit in the circuit court of Cook County, on behalf of a lady whose DePuy hip implant system not only had the component parts come loose, but also caused dangerously high levels of chromium and cobalt in her blood. By alleging that the distributor, Premier Orthopedic Sales, Inc., had knowledge of the defects I plan on strenously resisting all efforts of DePuy Orthopedics to remove this action to federal court.

Many of the nationwide lawsuits that have been filed against DePuy Orthopedics, Inc. in state courts have been removed to federal court by DePuy based on 28 U.S.C. 1441, which essentially allows defendants to remove lawsuits filed in state courts to federal court, if each defendant resides in a different state than the plaintiff, no defendant is a citizen of the state in which action brought, and the amount in controversy exceeds $75,000.

Should DePuy Orthopedics, Inc. attempt to remove an action filed in an Illinois state court to federal court in a lawsuit that names Premier Orthopedic Sales, Inc. as a defendant, this can be remanded back to state court if the case was plead properly. Pursuant to 28 U.S.C. 1447(c), plaintiff has thirty days after removal to file a motion to remand the suit back to state court.

In Kopitke v. DePuy Orthopaedics, Inc. and Premier Orthopaedic Sales, Inc. (2011 WL 856865), Judge Darrrah of U.S. Dist. Ct. for the N.D. of Illinois, remanded a lawsuit DePuy had removed to federal court. The court ruled that the distributor, Premier, was not fraudulently joined to destroy diversity jurisdiction and that the allegations complied with 745 ILCS5/2-621(c)(2). The Seventh Circuit has defined "fraudulent joinder" as "a claim against an in-state defendant that simply has no chance of success." Poulos v. Nass Foods, 959 F. 2d 69, 73 (1992). Allegations alone are insufficient to keep a case in state court since a defendant seeking removal is entitled to present facts showing that "the individuals joined in the action cannot be liable on any theory." Ritchey v. Upjohn, 139 F. 3d 1313, 1318 (9th Cir. 1998).

Lawsuits against DePuy for their recalled hip implant systems filed in federal court or removed to federal court, are all transferred to the U.S. Dist. Ct. for the Northern District of Ohio to a multi district litigation panel along with thousands of other lawsuits. Keeping your clients' cases in the Illinois state courts to be handled individually is far preferable to having your client share her or his day in court with thousands of other claimants. If a case can be filed in the Illinois state courts, it should be. In selecting an attorney to represent you in DePuy litigation, remember to select an attorney not only with experience in product liability cases but also an attorney with extensive jury trial experience. Should you so choose, feel free to call Edmund Scanlan toll free 877-494-1309 for a free consultation to discuss your options.


December 5, 2011

Online Malpractice Is Criminal

The business of prescribing and shipping prescription medications over the internet has been used by physicians and pharmacists to ship medication out of state based solely on an online questionnaire. This can be and frequently is a violation of federal law, and if it is intentional it is a felony.

Many attorneys do not wish to get involved in cases where patients accidentally or intentionally overdose on these medications. There are several reasons for this reluctance. First, they frequently involve drug addicts whose personal physicians would never prescribe these medications. Second, the patient, physician, and pharmacist generally all live in different states and there are significant issues as to which states' laws apply. These case can be and I have been bringing them in the federal courts with success.

These physicians, pharmacists and pharmacies are commonly committing felonies, namely the crime of misbranding, in violation of 21 U.S.C. 353(b), 21 U.S.C. 331(a) and (k). Pursuant to 21 U.S.C. 333(a)2 it is a felony if it is done with intent to defraud or mislead. Most of the websites state that the physicians and pharmacies are licensed in your local area. Few are licensed where the prescriptions are shipped.

A good analysis of misbranding can be found in U.S. v. Smith, 573 F.3d 639, 651 (8th Cir. 2009), where the Court of Appeals held a prescriptions is misbranded if it is not accompanied by some sort of physical examination of the patient. None of these websites offer or even contemplate the patient seeing a physician. They merely require an online questionnaire to be filled out, and. most importantly a credit card that clears. Prescriptions are frequently shipped that day or the next by Fed Ex.

Patients and their families are reluctant to come forward because the victim is commonly an addict. The physicians and pharmacists know this and rely on this hesitancy-but victims and families should step up and sue these professionals for the drug dealers that they are. After all, criminal prosecutions are instituted everyday against drug dealers selling drugs to addicts, why should these unethical and criminal professionals not be brought to justice and to have to answer financially for their criminal conduct. If you or a family member have received prescription drugs over the internet, and an overdose has occurred, feel free to contact Edmund Scanlan toll free at 877-494-1309 to discuss what actions may be taken. If nothing else you may be assured that they will not be repeating this conduct.

April 5, 2011

Illinois DePuy Hip Implant Recall Lawyers

Illinois product liability lawyers need to be aware of the August 2010 recall by DePuy Orthopedics of its defective metal-on-metal hip implant systems. The two hip implant systems recalled are the: (1) ASR XL Acetabular System, and (2) ASR Hip Replacement System, which first became available in 2003.

The most common problem with the ASR hip implant systems is that its components come loose. One of the design defects of these hip implant systems is that the cup-"acetabular prosthesis"-is too shallow causing it to: (1) dislocate, and (2) to shave cobalt and chromium off the metal-on-metal system and into the bloodstream when the joint's ball strikes against the cup's edge-"edge loading".

According to figures released by DePuy, 93,000 patients were implanted with these hip implants. There are current estimates that indicate that as high as 90% of patients with these hip implant systems will require revision surgery.

The most frequent symptoms experienced by patients are:
*dislocation of the hip
*metallosis and cobalt poisoning caused by chromium and cobalt being sheared off the system by"edge loading"
*fracture of the bone near the implant site
*sever pain
*inflammation and swelling
*significant difficulties walking
Metallosis can cause tissue breakdown and bone loss. Cobalt poisoning is even more insidious and can cause ringing in the ears-"tinnitus", vertigo, nerve atrophy, deafness, blindness, optic nerve atrophy, convulsions, headaches, and cardiomyopathy. Unfortunately these systems receive FDA approval through a process known as"510(K) approval process"-that did not require human tests.

DePuy Orthopedics, a division of Johnson & Johnson, is now contacting patients with these hip implant systems and offering "reasonable and customary costs of monitoring and treatment". These offers do not include:
*pain and suffering associated with the failure and the revision surgery
*medical complications that may be associated with the removal and installation of a new hip implant system
*lost wages
*any temporary or total disabilities cause by the failure
*DePuy also requires that patients submit their bills to their own insurance companies, Medicare, or other employee sponsored health plans before they consider paying medical expenses.

Patients with these DePuy ASR hip implant systems should be extremely cautious before entering into any agreement with DePuy or Johnson & Johnson. Anyone who has had these hip implant systems used in a hip replacement should contact an experienced product liability attorney to discuss your options. The best option may be to institute a product liability lawsuit to secure full compensation for all damages incurred, e.g. medical expenses, lost wages, pain and suffering, permanent disabilities, as well as damages for and complications incurred as a result of the revision surgery.

Should you so choose, feel free to call Edmund Scanlan toll free at 877-494-1309 for a free consultation to discuss your options. Our firm has extensive experience in product liability lawsuits and hip implant litigation in particular.

March 15, 2011

Online Medical and Pharmacy Malpractice

Physicians who prescribe drugs over the internet without seeing the patient and the pharmacies that fill and ship the drugs have sought to evade criminal and civil liability by prescribing non controlled substances. The DEA enforces the Federal Controlled Substances Act (21 U.S.C. 80 et seq.) which explicitly prohibits the sale of controlled substances prescribed by physicians who have never seen the patient.

Non controlled prescription drugs are governed by the Food, Drug and Cosmetics Act (21 U.S.C. 301 et seq.) which does not explicitly address online prescriptions and consultations. Criminal and civil prosecutions are now being pursued against these online pharmacies and physicians who sell, ship, and prescribe non controlled prescription drugs to patients based solely on an online questionnaire and "without some sort of examination." U.S. v. Smith, 573 F. 3d 639, 651 (8th Cir. 2009).

The legal theory behind these prosecutions is that online consultations with a physician is not the basis for a legitimate prescription, and therefore constitutes the crime of misbranding under the Food, Drug and Cosmetics Act (21 U.S.C. 353(b)(1), which is prohibited under 21 U.S.C. 331(a) and (k). The introduction or delivery into interstate commerce of a drug that is misbranded is punishable under 21 U.S.C. 333(a)(1), and as a felony under 21 U.S.C. 331(a)(2) if it is done with intent to defraud or mislead. The web pages of most online pharmacies that ship prescriptions without some sort of examination do both. Frequently neither the physician nor the pharmacy are licensed to prescibe or fill prescriptions in the state into which they are shipped.
In U.S. v. Smith, the Eighth Circuit stated: "A drug is misbranded unless dispensed upon "a prescription of a practictioner licensed by law to administer such drug." 573 F. 3d 639, 650 (2009). The Smith court described a "prescription drug as misbranded if it dispensed other than through a valid prescription." 573 F. 3d at 651. The Court defined "valid prescription" as "...a bona fide order-i.e. directions for the preparation and administration of a...drug for a real patient who actually needs it after some sort of examination..." 573 F. 3d at 651.

Continue reading "Online Medical and Pharmacy Malpractice" »

March 1, 2010

Avandia Linked To Heart Attacks

Illinois product liability attorneys should be aware that Avandia, a diabetes drug, is now linked to a higher risk of heart attack and heart failure according to a report released by the Senate Finance Committee on Feb. 20, 2010. The report authored by the committee chaired by Senators Baucus and Grassley concluded:

"The totality of evidence suggests that GSK (GlaxoSmithKline) was aware of the possible cardiac risks associated with Avandia years before such evidence became public....Based on this knowledge, GSK had a duty to sufficiently warn patients and the FDA of its concerns in a timely manner. Instead, GSK executives intimidated independent physicians, focused on strategies to minimize findings that Avandia may increase cardiovascular risk, and sought ways to downplay findings that the rival drug ACTOS (pioglitazone) might reduce cardiovascular risk."

According to recently released reports by the FDA if every diabetic taking Avandia were instead given a similar drug named Actos, about 500 heart attacks and 300 heart failures would be averted every month because Avandia can hurt the heart. Dr. David Graham and Dr. Kate Gelperin of the FDA stated in a report: "Rosiglitazone (Avandia) should be removed from the market."

Senator Max Baucus chairman of the Finance Committee said: "Americans have a right to know there are serious health risks associated with Avandia and GlaxoSmithKline had a responsibility to tell them. Patients trust drug companies with their health and lives and GlaxoSmithKline abused that trust." The first study to disclose the Avandia heart risk was released by the New England Journal of Medicine on May 21, 2007. The Senate report states that the FDA estimated in July 2007, that Avandia has been linked to 83,000 heart attacks since it was put on the market.

Currently most litigation is in federal court since GlaxoSmithKline is a British corporation and the cases have been consolidated for purposes of discovery in the U. S. District Court for the Eastern District of Pennsylvnia. Victims are still entitled to file the litigation in the federal court where they took the medication, but discovery will take place under the auspices of the federal judge in the federal court for the Eastern District of Pennsylvania. Now that evidence exists that GSK failed to warn of known risks of Avandis for years the prospect for success in Avandia litigation has increeased substantially. If you, a family member, or friend has had a heart attack while taking Avandia you should promptly consult with an attorney well versed in handling product liability litigation. Should you so choose feel free to contact Edmund Scanlan at 877-494-1309.

April 1, 2009

Yamaha Rhino Rollovers Prompt Recall

Illinois product liability attorneys should be aware that yesterday the Yamaha Motor Corp. recalled about 120,000 utility terrain vehicles (UTVs), namely the Rhino models 450, 660 and 700 models. The four wheel side by side Rhino manufactured by Yamaha has become one of the most popular UTVs sold in the U.S. The design flaws that prompted the recall include a top heavy design resulting in a high center of gravity and a track width that is too narrow.

The United States Consumer Product Safety Commission (CPSC), has announced a free repair program to address these issues. Of the more than 50 incidents investigated by the CPSC more than two thirds involved rollovers, many of which involve turns at relatively low speeds on level terrain.

Utility Terrain Vehicles have fallen within a regulatory crevice. These vehicles were introduced to the market and have been sold to consumers without having to meet government safety and performance standards. It is critical that federal and/or state state safety agencies act to protect consumers from the growing number of fatalities and severe injuries

Consumers who own any of the models involved should return the vehicle to their Yamaha dealer for free repairs. Repairs include installation of a spacer on the rear wheels as well as removal of the rear anti-sway bar to help reduce the the chance of rollover and to improve vehicle handling.

Consumers or anyone who have been injured or died in a rollover should immediately consult with a product liability attorney to ensure preservation of the vehicle and to begin appropriate engineering analysis. Should you wish you can call our office toll free 877-494-1309 for a prompt review of your case without charge or obligation

November 19, 2008

Duragesic Pain Patch Lawsuit Brings $16.6 Million Award

Illinois product liability lawyers are encouraged by the verdict returned November 17, 2008, in the Circuit Court of Cook County awarding $16.6 million in damages to the estate of a 38 year old Cicero woman who died of a fatal dose of the powerful narcotic fentanyl. The suit alleged that the defendants, New Jersy based Janssen Pharmaceutica Inc. and California based ALZA Corp. knew about problems with the Duragesic patch that allowed it to leak fentanyl in doses large enough to kill pateints. Both defendants are subsidiaries of Johnson & Johnson.

The defendants maintained that the decendent death was caused by "polypharmacy"- a mix of potentially incompatible medications. The jury disagreed. The verdict is the fourth trial loss since 2006. FDA had issued prior warnings about improper use of fentanyl patrches.

Post trial motions and a possible appeal are down the road, but multiple juries have now concluded that some of these Duragesic (fentanyl) patches are unreasonably dangerous. Unfortunately, federal preemption (see blog of Oct. 31, 08) may yet provide a opportunity for defendants to escape liability. Civil jury verdicts are pointing the way for FDA action.

October 31, 2008

State Product Liability Lawsuit Preemption before U.S. Supreme Court

Product liability lawsuit preemption by federal regulation is scheduled for oral argument before the U.S. Supreme Court on November 3, 2008. In 2000 a state court jury in Vermont awarded Diana Levine $6.5 million in a product liability lawsuit against Wyeth Pharmaceuticals. The outcome of Levine's case will have major ramifications for drug makers and consumers. The U.S. Supreme Court is expected to decide whether people can sue under state law or are pre-empted from doing so- for harm caused by a drug approved by the federal Food and Drug Administration.

In 2000 Diana Levine was prescribed an "IV push" of Phenergan to combat nausea brought upon by migraine headaches and pain killers she was taking. Unfortunately the "IV push" of Phenergan punctured an artery, causing her right arm to become gangrenous. After several weeks her right arm was amputated.

Levine sued Wyeth contending that the label of Phenergan should have more clearly warned about the danger of giving the "IV push." Combating an upset stomach with a method that can end up causing limb loss is an "unfathomable benefit-risk ratio" according to Diana Levine.

Wyeth maintains that when a drug like Phenergan has a federally approved label its manufacturer is immune from lawsuits in state court. Levine's position is that federaal regulation should represent the floor, not the ceiling, of a drug company's responsibility.

The Supreme Court of Vermont which affirmed the jury's verdict held that negligence and failure to warn claims on the labelling of an anti-nausea drug, "did not conflict with the FDA's labelling requirements...because Wyeth could have warned against the danger without prior FDA approval and because federal labelling regulations create a floor not a ceiling for state regulation." Levine v.Wyeth, 944 A. 2d 179 (Vt. 2006), cert. granted 128 S. Ct. 1118.

It is ironic that the Bush administration which has successfully pursued an agenda against federal regulatory oversight, will have its judicial appointees leading the way to eliminate pharmaceutical company liability utilizing federal regulations.

July 16, 2008

Old Tires Are Defective and Deadly

Tires older than 6 years old should not be used on motor vehicles since it can lead to tread separation and catastrophic failure. Since 2001 the British Rubber Manufactures Association (BRMA) have recommended: "BRMA members strongly recommend that unused tyres should not be put into service if they are over 6 years old and that all tyres should be replaced 10 years from the date of their manufacture." This is incredible since BRMA includes all the tire manufacturers who also sell in the United States. No such warnings have been given by tire manufacturers and retailers to consumers in the United States. Retailing giants in the U.S. like Walmart and Sears routinely sell tires as new in their stores that are routinely older than 6 years and sometimes as old as 17 years. This is unconscionable!

Like any other rubber product, tires have a limited service life regardless of tread depth and use. Tire age can be determined through decoding of the required DOT number printed on the side of a tire, but it is of no help to consumers because you must know the code to interpret when the tire was manufactured. Experts that I have worked with say that tire age is a silent killer because a consumer can purchase a brand new tire from a reputable retailer or outlet and have no idea that at the time of purchase the tire is already defective.

Ford Motor Company added a 6 year tire replacement recommendation, regardless of tread wear, to all 2006 owner's manuals. Finally, on June 2, 2008, the National Highway Transportation Safety Administration (NHTSA) issued a Consumer Advisory warning that aged tires, regardless of tread use, are subject to greater stress increasing the likelihood of catastrophic failure. Recent investigative reports point to corporate neglect and government inaction as the root cause of American consumers buying new tires that are defecive at the time of purchase.

Attorneys reviewing cases involoving tread separation must be alert to and agressively evaluate the age of the tire as a possible cause of the separation. Insurance industry data reflect that 84% of tire claims arise in tires over 6 years old. Securing the tire and retaining the appropriate tire safety experts are essential first steps for the attorney to take when pursuing these product liability claims. Tire manufacturers, automotive companies, and their retailers have long been aware of the dangers posed by marketing tires older than 6 years old, but have failed to warn consumers despite the deadly consequences. If tread separation occurs on a tire older than 6 years with deadly consequences, sue the bastards!

December 3, 2007

Product Liability Rollover Suit Not Preempted

A products liability suit in a rollover accident was not preempted by federal regulations according to a recent decision by the Fifth Circuit Court of Appeals. This decision rejects a common defense used by manufacturers in defending product liability claims brought by injured consumers claiming injuries from defective products. Plaintiff brought suit in a Texas state court against GM alleging serious injuries when she was partially ejected from the passenger side window of a Tahoe. The complaint alleged common law theories of strict liability and negligence for the defective design, manufacture, and marketing of the Tahoe’s side windows. Plaintiff claimed GM’s use of tempered glass in the side windows was unreasonably dangerous and that the use of advanced glazing would have decreased the likelihood of passenger ejection. GM removed the action to federal district court based on diversity jurisdiction.

The Fifth Circuit Court of Appeals succinctly stated the issue: “This appeal is about whether FMVSS 205, which governs motor vehicle safety, preempts a common law suit alleging that GM’s use of a permitted glazing technology was unsafe. We are the first appellate court to rule on this question.” O’Hara v. GM, (slip opinion at p. 6) (2007). GM argued that a 2002 decision to leave the existing standards regarding glazing intact (FMVSS 205) embodies a federal policy regarding motor vehicle glazing would be frustrated by a Texas common law rule requiring advanced glazing in side windows. GM contented thatGeier v. American Honda Motor Co., 5529 U.S. 861 (2000), which found that FMVSS 208 (the NHTSA safety standard for occupant crash protection) compelled preemption of state common law claims. Plaintiff contended that FMVSS 205 differs significantly from FMVSS 208 and that NHTSA’s decision not to require advance glazing in side windows left FMVSS 205 intact as a “minimum safety standard” that does not preempt state tort actions. Plaintiff further argued that NHTSA’s decision not to require advance glazing in side windows is similar to the Coast Guard’s decision not to require propeller guards, which was held to be non-preemptive inSprietsma v. Mercury Marine, 537 U.S. 51 (2002).

Conflict preemption was discussed with the Court stating: “Even where Congress has not completely displaced state regulation in a specific area, state law is nullified to the extent that it actually conflicts with federal law. Fid. Fed. Sav. & Loan Ass’n. v. de la Cuesta, 458 U.S. 141, 153 (1982). Federal regulations can have a preemptive effect equal to that of federal laws. Conflict preemption can arise in one of two ways, either when compliance with both federal regulations and state regulations is a physical impossibility or when state laws stands as an obstacle to the accomplishment and execution of the full purposes and objectives of Congress. The second form of implied conflict preemption is at issue here.”O’Hara v. GM, (slip opinion at p. 7) 2007.

In Sprietsma, The U.S. Supreme Court held that nothing in the Coast Guard’s official explanation for not requiring propeller guards on all boats “would be inconsistent with a tort verdict premised on a jury’s finding that some type of propeller guard should have been installed on this particular kind of boat” and that it did not “convey an authoritative message of a federal policy against propeller guards.” Sprietsma v. Mercury Marine, 537 U.S. 51, 67 (2002).

Continue reading "Product Liability Rollover Suit Not Preempted" »

June 4, 2007

Illinois Wrongful Death Act Amended

Illinois Wrongful Death Act now allows jurors to award damages for "grief, sorrow, and mental suffering." The law in Illinois since 1867 has been that in wrongful death actions, there is "no recovery for bereavement" and "nothing can be given as solatium." Chicago & A.R. Co. v. Shannon, 43 Ill. 338, 1867 WL 5039 (1867).

Jury instructions in wrongful death actions arising before the effective date of this amendment, May 31, 2007, have and will include Illinois Pattern Jury Instruction (Civil) IPI 31.07. This instructions states: In determining "pecuniary loss" you may not consider the following:
(1) The pain and suffering of the decedent;
(2) The grief or sorrow of the widow and next of kin, or
(3) The poverty or wealth of the widow and next of kin.

Needless to say this was and is a powerful argument that defendants, their insurers and attorneys make to jurors at the trial of a wrongful death action to limit the amount of damages awarded. Sometimes the only significant loss widows and next of kin sustain is the "grief, sorrow, and mental suffering" associated with the wrongfyl death of a family member.

Continue reading "Illinois Wrongful Death Act Amended" »

December 6, 2006

Illinois Product Liability Verdict of $27 Million Affirmed and Reversed

An Illinois product liability verdict against Ford Motor and Mazda Motors for defective design of driver's seat was affirmed, but the damage award of $27 million was reduced by an appellate court in Chicago on Nov. 22, 2006. On Feb. 4, 2000, decedent was a driver stopped at stoplight when he was rear ended by a drunk driver. On impact decedent's seat flattened backwards and he was ejected toward the rear of the car causing injuries that led to his death three days later.

Decedent's estate filed a product liability lawsuit in Chicago alleging that driver's seat was defectively designed with inadequate strength making it unreasonably dangerous. The driver's seat was co-designed by Ford and Mazda and was a "yielding seat" meaning that when force applied it yielded in the direction of the force. This "yielding seat" met federal safety standards. However, plaintiff's expert testified that compliance with federal safety standards does not make a seat safe. Expert testimony revealed that a "rigid seat" transfers the energy forward in a rear end collision.

Estate expert witnesses testified the a "rigid seat" was feasible and would have protected decedent from his fatal injuries. Specifically, experts opined that risk of severe to fatal injuries was 10 to 25 times greater with a "yielding seat."

Continue reading "Illinois Product Liability Verdict of $27 Million Affirmed and Reversed" »

November 21, 2006

Chicago Man's Crushed Leg Brings $1.8 Million in Product Liability Action

A Chicago product liability suit that I tried recently resulted in $1.8 million verdict to a 40 year old Chicago man whose leg was crushed on an assembly line. Many interesting legal issues arose including who should be placed on the jury verdict form regarding apportioning fault among defendants, third party defendants, and plaintiff (see previous post regarding this issue). In 2002 plaintiff was working on an assembly line that produced laminated boards for use as countertops and cabinets. At the end of the laminating line there was a scissors lift table which received the completed boards and which was operated by a foot switch.

While guiding boards onto the scissors lift plaintiff accidentally stepped on the foot switch causing the table to lower while his foot was underneath. The boards and table weighed over 1,500 lbs. and crushed his right leg. Plaintiff sustained fracture of tibial plateau, bimalleolar fracture of ankle requiring six surgeries and ultimately fusion of his knee. Plaintiff, a former drug user, complicated his medical condition by injecting Oxycontin into his right arm in an unsuccessful attempt to relieve pain, thus leading to osteomyelitis in his right leg.

Continue reading "Chicago Man's Crushed Leg Brings $1.8 Million in Product Liability Action " »

November 21, 2006

Chicago Appellate Court Puts Settling Defendants on Verdict Form

An Illinois wrongful death verdict arising out of a construction accident where a scaffold collapsed was reversed by the appellate court in Chicago. The Court did rule that the defendants had waived any right to challenge the award of $14,230,000. The issue as framed by the Appellate Court:

Is a defendant who settles with the plaintiff prior to trial still a "defendant sued by the plaintiff" within the meaning of section 2-1117 of the Code of Civil Procedure (735 ILCS 5/2-1117)? If we answer this question in the affirmative, then all defendants sued by the plaintiff, including those who settled prior to trial, may be included on the jury verdict form so that the fact finder can assign each defendant their degree of fault, if any. If we answer this question in the negative, then only those defendants who remain when the case is submitted to the fact finder may be included on the verdict form.
Ready v. United, 367 Ill. App. 3d 272, 854 N.E. 758, 2006 WL 2434935 (2006).

Continue reading "Chicago Appellate Court Puts Settling Defendants on Verdict Form" »